Introduction of Steam and Microfibre cleaning

[Thomson, Rachel EA]

Hi all,

We are currently undertaking a major review in relation to environmental hygiene within our own organisation. As part of this we are considering the potential infection control outcomes relating to the introduction of novel cleaning processes, with a particular interest in steam and microfibre cleaning. I am aware of the body of work being led by a number of health services, including Southern Health, but I am particularly interested in any recorded impact on patient outcomes as a result of introducing steam and microfibre cleaning by other healthcare services.

In our organisation we publicly report on a number of surveillance data including

* MRSA acquisitions (colonisation and infection) [these are reported to our State surveillance unit although not publicly reported at this time]

* VRE acquisitions (colonisation and infection)

* MRGN acquisitions (colonisation and infection)

* SAB, including HCA as separate from Community Onset

* Clostridium difficile infection, in particular HCA

I attach for the interest of subscribers the link to the publicly reported HCAI data in Tasmania, which our hospital data.
http://www.dhhs.tas.gov.au/__data/assets/pdf_file/0013/161023/Surveillance_Report_No_21_Quarter_1_2014.pdf

My question is; are any list members able or willing to share with me their HCAI data both before and after introducing steam and microfibre cleaning?

I would be happy to receive replies off-line if this enquiry.

Thanks
Rachel

……………………………………………………………………………..
Rachel Thomson
Nurse Unit Manager

Infection Prevention & Control Unit
Royal Hobart Hospital
Tasmanian Health Organisation-South
*: 03 62227882/8658

Level 4, H Block
48 Liverpool Street
Hobart, 7000

________________________________

CONFIDENTIALITY NOTICE AND DISCLAIMER
The information in this transmission may be confidential and/or protected by legal professional privilege, and is intended only for the person or persons to whom it is addressed. If you are not such a person, you are warned that any disclosure, copying or dissemination of the information is unauthorised. If you have received the transmission in error, please immediately contact this office by telephone, fax or email, to inform us of the error and to enable arrangements to be made for the destruction of the transmission, or its return at our cost. No liability is accepted for any unauthorised use of the information contained in this transmission.

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

[Glenys Harrington]

Hi Rachel,

This research publication may be of interest/use.

J Hosp Infect. 2012
Oct;82(2):114-21. doi: 10.1016/j.jhin.2012.06.014. Epub 2012 Aug 15.

Clinical and cost effectiveness of eight disinfection methods for terminal
disinfection of hospital isolation rooms contaminated with Clostridium
difficile 027.

Doan L1,
Forrest H,
Fakis A,
Craig J,
Claxton L,
Khare M.

Abstract

BACKGROUND:

Clostridium difficile spores can survive in the environment for months or
years, and contaminated environmental surfaces are important sources of
nosocomial C. difficile transmission.

AIM:

To compare the clinical and cost effectiveness of eight C. difficile
environmental disinfection methods for the terminal cleaning of hospital
rooms contaminated with C. difficile spores.

METHODS:

This was a novel randomized prospective study undertaken in three phases.
Each empty hospital room was disinfected, then contaminated with C.
difficile spores and disinfected with one of eight disinfection products:
hydrogen peroxide vapour (HPV; Bioquell Q10) 350-700 parts per million
(ppm); dry ozone at 25 ppm (Meditrox); 1000 ppm chlorine-releasing agent
(Actichlor Plus); microfibre cloths (Vermop) used in combination with and
without a chlorine-releasing agent; high temperature over heated dry
atomized steam cleaning (Polti steam) in combination with a sanitizing
solution (HPMed); steam cleaning (Osprey steam); and peracetic acid wipes
(Clinell). Swabs were inoculated on to C. difficile-selective agar and
colony counts were performed pre and post disinfection for each method. A
cost-effectiveness analysis was also undertaken comparing all methods to the
current method of 1000 ppm chlorine-releasing agent (Actichlor Plus).

FINDINGS:

Products were ranked according to the log(10) reduction in colony count from
contamination phase to disinfection. The three statistically significant
most effective products were hydrogen peroxide (2.303); 1000 ppm
chlorine-releasing agent (2.223) and peracetic acid wipes (2.134).

CONCLUSION:

The cheaper traditional method of using a chlorine-releasing agent for
disinfection was as effective as modern methods.

Regards

Glenys

Glenys Harrington

Consultant

Infection Control Consultancy (ICC)

PO Box 5202

Middle Park

Victoria, 3206

Australia

H: +61 3 96902216

M: +61 404 816 434

infexion@ozemail.com.au

ABN 47533508426

Of Thomson, Rachel EA (DHHS)
cleaning

Hi all,

We are currently undertaking a major review in relation to environmental
hygiene within our own organisation. As part of this we are considering the
potential infection control outcomes relating to the introduction of novel
cleaning processes, with a particular interest in steam and microfibre
cleaning. I am aware of the body of work being led by a number of health
services, including Southern Health, but I am particularly interested in any
recorded impact on patient outcomes as a result of introducing steam and
microfibre cleaning by other healthcare services.

In our organisation we publicly report on a number of surveillance data
including

. MRSA acquisitions (colonisation and infection) [these are reported
to our State surveillance unit although not publicly reported at this time]

. VRE acquisitions (colonisation and infection)

. MRGN acquisitions (colonisation and infection)

. SAB, including HCA as separate from Community Onset

. Clostridium difficile infection, in particular HCA

I attach for the interest of subscribers the link to the publicly reported
HCAI data in Tasmania, which our hospital data.

http://www.dhhs.tas.gov.au/__data/assets/pdf_file/0013/161023/Surveillance_R
eport_No_21_Quarter_1_2014.pdf

My question is; are any list members able or willing to share with me their
HCAI data both before and after introducing steam and microfibre cleaning?

I would be happy to receive replies off-line if this enquiry.

Thanks

Rachel

………………………….

Rachel Thomson

Nurse Unit Manager

Infection Prevention & Control Unit

Royal Hobart Hospital

Tasmanian Health Organisation-South

(: 03 62227882/8658

rachel.thomson@dhhs.tas.gov.au

Level 4, H Block

48 Liverpool Street

Hobart, 7000

_____

CONFIDENTIALITY NOTICE AND DISCLAIMER
The information in this transmission may be confidential and/or protected by
legal professional privilege, and is intended only for the person or persons
to whom it is addressed. If you are not such a person, you are warned that
any disclosure, copying or dissemination of the information is unauthorised.
If you have received the transmission in error, please immediately contact
this office by telephone, fax or email, to inform us of the error and to
enable arrangements to be made for the destruction of the transmission, or
its return at our cost. No liability is accepted for any unauthorised use of
the information contained in this transmission.

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO
NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is
discouraged by ACIPC. If you wish to discuss specific reference to products
or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives –
registration and login required.

Replies to this message will be directed back to the list. To create a new
message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to
aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without
the quotes) to listserv@aicalist.org.au

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

[Thomson, Rachel EA]

Hi Glenys,

Yes I found that one in my research to date. I am interested in the experience of Australian Healthcare facilities, and I particularly interested in the impact (if any) on HAIs. It will be interesting to see if anyone can share some outcome data aligned to this practice change.

Thanks & speak soon
Rachel

……………………………………………………………………………..
Rachel Thomson
Nurse Unit Manager

Infection Prevention & Control Unit
Royal Hobart Hospital
Tasmanian Health Organisation-South
*: 03 62227882/8658

Level 4, H Block
48 Liverpool Street
Hobart, 7000

Hi Rachel,

This research publication may be of interest/use.

J Hosp Infect. 2012 Oct;82(2):114-21. doi: 10.1016/j.jhin.2012.06.014. Epub 2012 Aug 15.
Clinical and cost effectiveness of eight disinfection methods for terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027.
Doan L1, Forrest H, Fakis A, Craig J, Claxton L, Khare M.

Abstract
BACKGROUND:
Clostridium difficile spores can survive in the environment for months or years, and contaminated environmental surfaces are important sources of nosocomial C. difficile transmission.
AIM:
To compare the clinical and cost effectiveness of eight C. difficile environmental disinfection methods for the terminal cleaning of hospital rooms contaminated with C. difficile spores.
METHODS:
This was a novel randomized prospective study undertaken in three phases. Each empty hospital room was disinfected, then contaminated with C. difficile spores and disinfected with one of eight disinfection products: hydrogen peroxide vapour (HPV; Bioquell Q10) 350-700 parts per million (ppm); dry ozone at 25 ppm (Meditrox); 1000 ppm chlorine-releasing agent (Actichlor Plus); microfibre cloths (Vermop) used in combination with and without a chlorine-releasing agent; high temperature over heated dry atomized steam cleaning (Polti steam) in combination with a sanitizing solution (HPMed); steam cleaning (Osprey steam); and peracetic acid wipes (Clinell). Swabs were inoculated on to C. difficile-selective agar and colony counts were performed pre and post disinfection for each method. A cost-effectiveness analysis was also undertaken comparing all methods to the current method of 1000 ppm chlorine-releasing agent (Actichlor Plus).
FINDINGS:
Products were ranked according to the log(10) reduction in colony count from contamination phase to disinfection. The three statistically significant most effective products were hydrogen peroxide (2.303); 1000 ppm chlorine-releasing agent (2.223) and peracetic acid wipes (2.134).
CONCLUSION:
The cheaper traditional method of using a chlorine-releasing agent for disinfection was as effective as modern methods.
Regards

Glenys

Glenys Harrington
Consultant
Infection Control Consultancy (ICC)

PO Box 5202
Middle Park
Victoria, 3206
Australia
H: +61 3 96902216
M: +61 404 816 434
infexion@ozemail.com.au
ABN 47533508426

Hi all,

We are currently undertaking a major review in relation to environmental hygiene within our own organisation. As part of this we are considering the potential infection control outcomes relating to the introduction of novel cleaning processes, with a particular interest in steam and microfibre cleaning. I am aware of the body of work being led by a number of health services, including Southern Health, but I am particularly interested in any recorded impact on patient outcomes as a result of introducing steam and microfibre cleaning by other healthcare services.

In our organisation we publicly report on a number of surveillance data including

* MRSA acquisitions (colonisation and infection) [these are reported to our State surveillance unit although not publicly reported at this time]

* VRE acquisitions (colonisation and infection)

* MRGN acquisitions (colonisation and infection)

* SAB, including HCA as separate from Community Onset

* Clostridium difficile infection, in particular HCA

I attach for the interest of subscribers the link to the publicly reported HCAI data in Tasmania, which our hospital data.
http://www.dhhs.tas.gov.au/__data/assets/pdf_file/0013/161023/Surveillance_Report_No_21_Quarter_1_2014.pdf

My question is; are any list members able or willing to share with me their HCAI data both before and after introducing steam and microfibre cleaning?

I would be happy to receive replies off-line if this enquiry.

Thanks
Rachel

……………………………………………………………………………..
Rachel Thomson
Nurse Unit Manager

Infection Prevention & Control Unit
Royal Hobart Hospital
Tasmanian Health Organisation-South
*: 03 62227882/8658

Level 4, H Block
48 Liverpool Street
Hobart, 7000

________________________________

CONFIDENTIALITY NOTICE AND DISCLAIMER
The information in this transmission may be confidential and/or protected by legal professional privilege, and is intended only for the person or persons to whom it is addressed. If you are not such a person, you are warned that any disclosure, copying or dissemination of the information is unauthorised. If you have received the transmission in error, please immediately contact this office by telephone, fax or email, to inform us of the error and to enable arrangements to be made for the destruction of the transmission, or its return at our cost. No liability is accepted for any unauthorised use of the information contained in this transmission.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

________________________________

CONFIDENTIALITY NOTICE AND DISCLAIMER
The information in this transmission may be confidential and/or protected by legal professional privilege, and is intended only for the person or persons to whom it is addressed. If you are not such a person, you are warned that any disclosure, copying or dissemination of the information is unauthorised. If you have received the transmission in error, please immediately contact this office by telephone, fax or email, to inform us of the error and to enable arrangements to be made for the destruction of the transmission, or its return at our cost. No liability is accepted for any unauthorised use of the information contained in this transmission.

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

[Author]

Posts